Enhancing Conservative Treatment for Urge Incontinence
NCT00223821
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
166
Enrollment
FED
Sponsor class
Conditions
Urinary Incontinence
Interventions
DRUG:
Oxybutynin chloride, extended-release, individually-titrated
BEHAVIORAL:
Behavior Training
Sponsor
US Department of Veterans Affairs